Abstract
Since the discovery of the blocker properties of dichloroisoproterenol by Powell and Slater in 1958 [2], fl-adrenergic receptor antagonists have found wide applications in the treatment of hypertension, cardiac arrhythmias, agina pectoris, and other cardiovascular disorders. Recently proposed for the treatment of hypertension, bisoprolol is a selective fl-1 adrenergic antagonist with no membrane stabilizing effect and intrinsec sympathomimetic activity [1]. Previously, we have developed a high-performance liquid chromatographic (HPLC) method allowing the assay of the commonly prescribed fl-blockers, which is convenient for both routine analyses and pharmacokinetic experiments [3]. The present observation develops our earlier technique for bisoprolol.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
